Article Details
Retrieved on: 2021-12-26 14:52:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
GSA Capital Partners LLP purchased a new position in Matinas BioPharma in the second quarter valued at about $1,306,000. Sargent Investment Group LLC ...
Article found on: etfdailynews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here